Discontinuation report TUSSIONEX
Report ID | 19700 |
Drug Identification Number | 01916963 |
Brand name | TUSSIONEX |
Common or Proper name | TUSSIONEX 5-10MG TABLETS |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | HYDROCODONE PHENYLTOLOXAMINE |
Strength(s) | 5MG 10MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100's |
ATC code | R05DA |
ATC description | COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2017-08-03 |
Remaining supply date | 2017-01-03 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Inventory depleted as of January 3, 2017 |
Company comments | Business decision to discontinue product, no longer intend to meet demand as of August 3, 2017 |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-08-17 | English | Compare |
v2 | 2017-08-17 | English | Compare |
v3 | 2017-08-17 | French | Compare |
v4 | 2017-08-22 | English | Compare |
v5 | 2017-08-22 | French | Compare |
Showing 1 to 5 of 5